Bendamustine and subcutaneous alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients

被引：4

作者：

Montillo, Marco ^{[1
]}

Tedeschi, Alessandra ^{[1
]}

Gaidano, Gianluca ^{[2
]}

Coscia, Marta ^{[3
,4
]}

Petrizzi, Valeria Belsito ^{[5
]}

Orlandi, Ester ^{[6
]}

Cascavilla, Nicola ^{[7
]}

Ghia, Paolo ^{[8
,9
]}

Motta, Marina ^{[10
]}

Gallamini, Andrea ^{[11
]}

Frustaci, Anna Maria ^{[1
]}

Rossi, Davide ^{[2
]}

De Paoli, Lorenzo ^{[2
]}

Nichelatti, Michele ^{[12
]}

Morra, Enrica ^{[1
]}

Massaia, Massimo ^{[3
,4
]}

机构：

[1] Osped Niguarda Ca Granda, Niguarda Canc Ctr, Dept Haematol Oncol, Milan, Italy

[2] Amedeo Avogadro Univ Eastern Piedmont, Dept Translat Med, Div Hematol, Novara, Italy

[3] Univ Turin, Div Hematol, Turin, Italy

[4] Ctr Expt Res & Med Studies, Turin, Italy

[5] Gen Hosp, Oncol & Hematol Unit, Nocera Inferiore, Italy

[6] Fdn IRCCS Policlin San Matteo, Hematol Unit, Dept Hematol Oncol, Pavia, Italy

[7] IRCCS Casa Sollievo Sofferenza, Hematol Unit, San Giovanni Rotondo, Italy

[8] Ist Sci San Raffaele, Dept Oncohematol, Lymphoma Unit, I-20132 Milan, Italy

[9] Univ Vita Salute San Raffaele, Milan, Italy

[10] Spedali Civil Brescia, Div Hematol, I-25125 Brescia, Italy

[11] Cuneo Hosp, Div Hematol, Milan, Italy

[12] Osped Niguarda Ca Granda, Niguarda Canc Ctr, Serv Biostat, Milan, Italy

来源：

HAEMATOLOGICA | 2014年 / 99卷 / 09期

关键词：

bendamustine; effective treatment; relapsed/refractory chronic lymphocytic leukemia; PREVIOUSLY UNTREATED PATIENTS; PHASE-II TRIAL; FLUDARABINE; CYCLOPHOSPHAMIDE; RITUXIMAB; GUIDELINES; DIAGNOSIS;

D O I：

10.3324/haematol.2014.106740

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E159 / E161

页数：3

共 50 条

[1] Final Report of Bendamustine and Alemtuzumab (BEN CAM) Combination in Relapsed and Refractory Chronic Lymphocytic Leukemia
Tedeschi, Alessandra
Rossi, Davide
Coscia, Marta
Vismara, Eleonora
Petrizzi, Valeria Belsito
Orlandi, Ester
Cascavilla, Nicola
Scarfo, Lydia
Motta, Marina
Vitale, Candida
Ricci, Francesca
De Paoli, Lorenzo
D'Arco, Alfonso Maria
Gallamini, Andrea
Gaidano, Gianluca
Morra, Enrica
Massaia, Massimo
Montillo, Marco
BLOOD, 2012, 120 (21)
[2] EFFICACY OF THE COMBINATION OF BENDAMUSTINE AND RITUXIMAB IN PATIENTS WITH RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
Zagoskina, T.
Zotina, E.
Ovsepyan, V.
Shardakov, V.
HAEMATOLOGICA, 2014, 99 : 591 - 591
[3] EFFICACY OF COMBINATION FLUDARABINE AND ALEMTUZUMAB IN PATIENTS WITH RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
Zagoskina, T.
Zotina, E.
Malykh, O.
HAEMATOLOGICA, 2012, 97 : 305 - 305
[4] Idelalisib in Combination With Rituximab or Bendamustine or Both in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
Coutre, Steven E.
Flinn, Ian W.
de Vos, Sven
Barrientos, Jacqueline C.
Schreeder, Marshall T.
Wagner-Johnson, Nina D.
Sharman, Jeff P.
Boyd, Thomas E.
Fowler, Nathan
Dreiling, Lyndah
Kim, Yeonhee
Mitra, Siddhartha
Rai, Kanti
Leonard, John P.
Furman, Richard R.
HEMASPHERE, 2018, 2 (03):
[5] Efficacy Of Bendamustine and Rituximab In Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
Kataeva, Elena
Golenkov, Anatoly
Triphonova, Elena
Dudina, Galina
Mitina, Tatyana
Lutskaya, Tatyana
Vysotskaya, Ludmila
Chernykh, Yulliya
Zakharov, Sergey
BLOOD, 2013, 122 (21)
[6] Alemtuzumab in relapsed or refractory chronic lymphocytic leukemia and prolymphocytic leukemia
McCune, SL
Gockerman, JP
Moore, JO
Decastro, CM
Bass, AJ
Chao, NJ
Long, GD
Vredenburgh, JJ
Gasparetto, C
Adams, D
Payne, N
Rizzieri, DA
LEUKEMIA & LYMPHOMA, 2002, 43 (05) : 1007 - 1011
[7] Alemtuzumab Use In Relapsed and Refractory Chronic Lymphocytic Leukemia
Arnason, Jon E.
Brown, Jennifer R.
HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM, 2011, : 119 - 120
[8] A pilot trial of rituximab and alemtuzumab combination therapy in patients with relapsed and/or refractory chronic lymphocytic leukemia (CLL)
Nabhan, C
Patton, D
Gordon, LI
Riley, MB
Kuzel, T
Tallman, MS
Rosen, ST
LEUKEMIA & LYMPHOMA, 2004, 45 (11) : 2269 - 2273
[9] Pharmacokinetics of alemtuzumab in combination with fludarabine in patients with relapsed or refractory B-cell chronic lymphocytic leukemia
Elter, Thomas
Kilp, Julia
Borchmann, Peter
Schulz, Holger
Hallek, Michael
Engert, Andreas
Haematologica-The Hematology Journal, 2009, 94 (01): : 150 - 152
[10] Fludarabine and cyclophosphamide in combination with alemtuzumab in patients with primary high-risk, relapsed or refractory chronic lymphocytic leukemia
Elter, T.
James, R.
Busch, R.
Winkler, D.
Ritgen, M.
Boettcher, S.
Kahl, C.
Gassmann, W.
Stauch, M.
Hasan, I.
Staib, P.
Fischer, K.
Fink, A-M
Bahlo, J.
Buehler, A.
Doehner, H.
Wendtner, C-M
Stilgenbauer, S.
Engert, A.
Hallek, M.
LEUKEMIA, 2012, 26 (12) : 2549 - 2552

← 1 2 3 4 5 →